openPR Logo
Press release

Antiviral Drug Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

05-28-2020 07:16 AM CET | Health & Medicine

Press release from: Orion Market Research

The global antiviral drugs market is estimated to witness significant growth during the forecast period. Increasing viral infections such as Human immune deficiency virus (HIV), influenza A & B, hepatitis B & C are the major driving factor of the global antiviral drug market. There have been considerable advances in the innovation as well as the demand for HIV drugs. According to UN India, Pakistan and China are among the top 10 nations, that account for 95% of the total HIV infection cases in 2017. According to Avert, in 2017,an estimated 2.1 million people of India are living with HIV, 88,000 people got infected by HIV in this year and 69,000 AIDS-related deaths happened. Hence, growing number of HIV positive cases is creating hugh demand for antiviral drugs.

A full Report of Antiviral Drug Market Available at

Growing investment for research and development and drug development is expected to drive the global antiviral drugs market. For instance, in December 2019, NIH and Bill & Melinda Gates Foundation collaborated on Gene-based HIV cure treatment, they invested a total of $200 million. In October 2019, the US Food and Drug Administration (FDA) approved tenofovir Elafenamide 25 mg and Emtricitabine 200 mg to reduce the risk of HIV infection through sex. In April 2019, Dolutegravir and Lamivudine got approval from the US FDA, it can be used for a regimen for treatment-nave adults with HIV-1. Moreover, in March 2020, for the second time, a patient cured of HIV infection.

Request a Free Report on Sample of Antiviral Drug Market @

Hepatitis is a viral infection, it damages the liver. According to Avert, each year, around 1.75 million new people got affected by Hepatitis C. According to WHO, in 2015, an estimated 1% of the world population are living with Hepatitis C. Among them, 20% were aware of it and 7.4% among was diagnosed, and in 2016 this increased to 13%. In August 2017, the US FDA approved Mavyret (glecaprevir/pibrentasvir), it can be used for the treatment of six genotypes of Hepatitis-C. In July 2017, the US FDA approved Vosevi (sofosbuvir/velparasvir/voxilapre), it can be used for treatment for any genotype of hepatitis C. It is intended for those people who were previously treated with sofosbuvir but hadn't get viral clearance.

Among these viral infections, Influenza is an acute viral infection. According to the World Health Organization (WHO), in the northern fraction, approximately 5-15% of the population has been affecting by Influenza flu annually, and Clinical Infection Diseases (CID, Oxford Academic) found that the attack rate of Influenza, a median 9.3% are for the age group 0-17 years, 8.8% for 18-64 years, and 3.9% for 65 years and older. According to the Center for Disease Control and Prevention, the Us, from October 2019 to March 2020 there has been 36,000,000-51,000,000 Influenza flu illness happened, among them, 17,000,000-24,000,000 visited medical centers, 370,000-670,000 were hospitalized and 22,000-55,000 death case happened. In October 2018, Harvard Medical School developed a drug for Influenza flu, Baloxavir (Xofluza) and got approval from the US FDA. It can be used for treatment for both influenza A & B.

Global Antiviral Drugs Market Segmentation

By Application

o Influenza (Flu) Antiviral Drugs
o Hepatitis Antiviral Drugs
o HIV Antiviral Drugs
o Herpes Antiviral Drugs
o Others

By Types

o Branded
o Generic

Segment by Region

North America

o US
o Canada


o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe


o China
o Japan
o India
o Rest of Asia-Pacific

Rest of the World

For More Customized Data, Request for Report Customization @

For More Information, Visit
Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antiviral Drug Market Trends, Size, Competitive Analysis and Forecast - 2019-2025 here

News-ID: 2060181 • Views: 258

More Releases from Orion Market Research

Clean Room Robot Market Size, Industry Trends, Share and Forecast 2019-2025
The Clean Room Robot report is a comprehensive market research report that studies the challenges, market structure, opportunities, momentum, emerging trends and competitive landscape of the semiconductor and electronics industry. We provide better ideas and solutions in terms of product trends, marketing strategies, future products, new geographic markets, future events, sales strategies, customer behavior or behavior. The market insight covered by the Clean Room Robot Market report successfully simplifies the
Global Space Propulsion Systems Market Size, Industry Trends, Share and Forecast …
BIS Research's Global Space Propulsion Systems Market report predicts that the market will grow at a CAGR of 11% on a value basis over the forecast period 2020-2025. Share of 44.20% in 2019. North America, including major countries such as the United States, is the most prominent region in the space propulsion system market. The presence of major players and the fierce competition between them makes North America the most
Indian Healthcare Packaging Market Size, Industry Trends, Share and Forecast 202 …
The Indian healthcare packaging market is anticipated to grow at a significant CAGR of 8.9% during the forecast period (2020-2026). In India, the pharmaceutical sector is amongst the sectors are showing considerable growth since the last few decades. India is ranked as a 3rd across the globe for production by volume and 10th by value. According to Invest India information, the domestic pharmaceuticals market turnover reached $20.03 billion in 2019,
North American Healthcare Packaging Market Growth, Size, Share, Industry Report …
The North American healthcare packaging market is anticipated to grow at a CAGR of 5.3% during the forecast period (2020-2026). The increasing concerns regarding the environmental issues are driving the demand for biodegradable healthcare packaging across the region, which in turn, aiding to the growth of the North American healthcare packaging industry. In addition to this, disposable medical packaging is also experiencing a rise in demand, which will also expand

All 5 Releases

More Releases for HIV

Global HIV Market to 2024
The HIV market was valued at $16bn in 2015 and is forecast to expand at a CAGR of 3.7% between 2015 and 2024, culminating in 2024 global sales of $23bn.The expected arrival of new classes of therapies could result in a paradigm shift in the treatment of HIV treatment. Globally, around 35 million people are infected with HIV. Approximately 3 million people in the U.S and 2.5 million in top 5
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Global HIV Infection Pipeline Analysis
The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have
Global HIV Therapeutics Market
The HIV Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The human immunodeficiency virus (HIV) refers to a type of retrovirus that causes acquired immunodeficiency syndrome (AIDS). HIV attacks some immune cells and causes weakness of immune system resulting in loss
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral